Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

aTYR PHARMA (ATYR) Other Operating Expenses (2024 - 2025)

aTYR PHARMA's Other Operating Expenses history spans 2 years, with the latest figure at -$84.2 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 329.49% year-over-year to -$84.2 million; the TTM value through Dec 2025 reached -$111.7 million, down 137.2%, while the annual FY2025 figure was -$95.1 million, 13.91% down from the prior year.
  • Other Operating Expenses reached -$84.2 million in Q4 2025 per ATYR's latest filing, down from -$3.9 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of -$2.8 million in Q2 2024 to a low of -$84.2 million in Q4 2025.